DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20210477

Evaluation of hepatoprotective potential of aqueous extract of Withania somnifera in albino rats

Monica Sharma, Anand Gaur, Pinki Vishwakarma, Raj Kumar Goel, K. K. Saxena

Abstract


Background: Hepatic diseases are a major cause of morbidity and disability of work force throughout the world. The treatment of hepatic diseases with standard drugs poses the risk of toxicity on various organ systems. Withania somnifera, a herbal plant has been claimed to be effective in the treatment of various types of hepatic conditions. The present study was undertaken to explore the hepatoprotective activity of aqueous extract of Withania somnifera (AEWS) in experimentally induced hepatotoxicity in albino rats.

Methods: The study was commenced after obtaining approval from institutional animal ethical committee using AEWS leaves in Albino wistar rats (150-200 gm) of either sex. The hepatoprotective activity was evaluated using biochemical examination. The animals were divided into five groups of six animals each. In each experiment, first group was given normal saline (1 ml/kg/day), second group was injected with toxin CCl4 (1 ml/kg) i.p only once to produce hepatotoxicity, third and fourth groups were given Withania somnifera orally (500 mg/kg and 1000 mg/kg) (respectively), as a single dose per orally every morning and fifthgroup was given standard drug Liv-52 (1 mg/kg).

Results: Aqueous extract of Withania somnifera leaves in oral dose exhibited significant hepatoprotective effect in all models used in this study.

Conclusions: It can be concluded from our study that aqueous extract of Withania somnifera leaves possesses hepatoprotective activity.


Keywords


Hepatoprotective, Albino rats, Withania somnifera, Carbon tetrachloride

Full Text:

PDF

References


Jan AT, Azam M, Siddiqui K, Ali A, Choi I, Haq QM. Heavy metals and human health: mechanistic insight into toxicity and counter defense system of antioxidants. Int J Mol Sci. 2015;16(12):29592-630.

Demirdag K, BakceciogluIH, OzercanIH, Ozden M, Yilmaz S, Kalkan A. Role of L-carnitine in the prevention of acute liver damage induced by carbon tetrachloride in rats. J Gastroenterol Hepatol. 2004; 19:333-8.

Ernst E. The role of complementary and alternative medicine. Brit Medi J. 2000;321:1133-5.

Kessler RC, Davis RB, Foster DF, Van Rompay MI, Walters EE, Wilkey SA, et al. Long-term trends in the use of complementary and alternative medical therapies in the United States. Ann Int Med. 2001;135:262-8.

Williamson EM. Major herbs of ayurveda. London: Churchill Livingstone; 2002: 322-323.

Misra LC, Singh BB, Degenais S. Scientific basis for the therapeutic use of Withaniasomnifera (ashwagandha): a review. Alt Med Rev. 2000;5:334-46.

Kaur T, Singh H, Mishra R. Withania somnifera as a potential anxiolytic and immunomodulatory agent in acute sleep deprived female Wistar rats. Mol Cell Biochem. 2017;427:91-101.

Ojha SK, Arya DS. Withaniasomnifera Dunal (Ashwagandha): A promising remedy for cardiovascular diseases. World J Med Sci.2009;4: 156-8.

Bhattacharya A, Ramanathan M, Ghosal S, Bhattacharya SK. Effect of Withaniasomnifera Glycowithanolides on iron induced hepatotoxicity in rats. Phytother Res. 2000;14:568-70.

Wixson SK, White WJ. A comparison of pentobarbital, fentanyl-droperdiol, ketamine-xylazine and ketamine-diazepam anesthesia in adult male rats. LAS. 1987;37(6):726-30.

Ghosh MN. Fundamentals of experimental pharmacology. 4th ed. Kolkata: Hilton & Company; 2008:235-7.

Contreras-Zentella ML, Hernández-Muñoz R. Is liver enzyme release really associated with cell necrosis induced by oxidant stress?. Oxid Med Cell Longev. 2016;2016:3529149.

Ferreira EA, Gris EF, Felipe KB. Potent hepatoprotective effect in CCl (4)-induced hepatic injury in mice of phloroacetophenone from Myrcia multiflora. Libyan J Med. 2010;5:10.

Poli G. Pathogenesis of liver fibrosis: role of oxidative stress. Mol Aspect Med. 2000;21(3):49-98.

Akbartabar TM, Joodi B, Sadeghi H. Hepatoprotective activity of aerial parts of Otostegia persica against carbon tetrachloride-induced liver damage in rats. Avicenna J Phytomed. 2015;5(3): 238-46.

El-Bahr SM. Effect of curcumin on hepatic antioxidant enzymes activities and gene expressions in rats intoxicated with aflatoxin B1. Phytother Res. 2015;29(1):134-40.

Kaur M, Jindal R. Oxidative stress response in liver, kidney and gills of ctenopharyngodon idellus (cuvier & valenciennes) exposed to chlorpyrifos. MOJ Biol Med. 2017;1(4):103-12.

Kurutas EB. The importance of antioxidants which play the role in cellular response against oxidative/nitrosative stress: current state. Nutr J. 2016;15(1):71.

Hasanuzzaman M, Nahar K, Anee TI, Fujita M. Glutathione in plants: biosynthesis and physiological role in environmental stress tolerance. Physiol Mol Biol Plants. 2017;23(2):249-68.

Hayes JD, Flanagan JU, Jowsey IR. Glutathione transferases. Annual review of pharmacology and toxicology. 2005;45:51-88.

Ayala A, Muñoz MF, Argüelles S. Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid Med Cell Longev. 2014;2014:360438.

Scartezzini P, Speroni E. Review on some plants of Indian traditional medicine with antioxidant activity. J Ethanopharmacol. 2000;71:23-43.

Russo A, Izzo AA, Cardile V, Borrelli F, Vanella A. Indian medicinal plants as antiradicals and DNA cleavage protectors. Phytomed. 2001;8:125-32.

Gupta SK, Dua A, Vohra BP. Withania somnifera (Ashwagandha) attenuates antioxidant defense in aged spinal cord and inhibits copper induced lipid peroxidation and protein oxidative modifications. Drug Metab Drug Interact. 2003;19:211-22.

Kaur P, Sharma M, Mathur S, Tiwari M, Divekar HM, Kumar R, et al. Effect of 1-oxo-5beta, 6beta-epoxy-witha- 2-ene-27-ethoxyolide isolated from the roots of Withania somnifera on stress indices in Wistar rats. J Alt Complement Med. 2003;9:897-907.

RajaSankar S, Manivasagam T, Sankar V, Prakash S, Muthusamy R, Krishnamurti A, et al. Withania somnifera root extract improves catecholamines and physiological abnormalities seen in a Parkinson's disease model mouse. J Ethanopharmacol. 2009;125:369-73.